Results

Total Results: 194 records

Showing results for "risk".

41. Statin Use for the Primary Prevention of CVD in Adults: Patient-facing CDS Intervention (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final_1.pdf
    April 01, 2021 - factors for heart disease and stroke. • Provide educational resources about the risks for developing … factors, and identification of resources to address those risks. … Suggested Action: Provide educational materials that explain CVD risks pertinent to this recommendation … levels” instead of clinical descriptions), along with ways to modify those risks, such as taking a … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

42. Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final.pdf
    September 01, 2019 - factor for heart disease and stroke, (2) provide educational resources about the risks for developing … appointment, the primary care clinician provides educational information to the patient about their risks … factors, and identification of resources to address those risks. … Suggested Action: Provide educational materials that explain CVD risks pertinent to this recommendation … language (having high blood pressure or high cholesterol levels), along with ways to modify those risks

43. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
    October 01, 2017 - to address this risk. 2. … on his overall cardiac risk. … The risk score display is presented as part of the assessment, showing his current risk. … Provide the patient with information resources that outline benefits, risks, effects, and evidence behind … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

44. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - • Provide educational resources about the risks for developing CVD and the role that statin therapy … factors, and identification of resources to address those risks. … Suggested Action: Provide educational materials that explain CVD risks pertinent to this recommendation … levels” instead of clinical descriptions), along with ways to modify those risks, such as taking a … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

45. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/508_2022_CDS_Connect_IG_Statin_CVD_Patient_Facing_final.pdf
    January 01, 2022 - • Provide educational resources about the risks for developing CVD and the role that statin therapy … factors, and identification of resources to address those risks. … Suggested Action: Provide educational materials that explain CVD risks pertinent to this recommendation … levels” instead of clinical descriptions), along with ways to modify those risks, such as taking a … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

46. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2023 - in reducing their risk. … appointment, the primary care clinician provides educational information to the patient about their personal risks … factors, and identification of resources to address those risks. … Patient has a terminal condition, and the risks of preventive treatment outweigh benefits. 9 … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

47. Pilot Site Training For Pain Management Summary Cds For Repository (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS%20for%20Repository.pdf
    May 24, 2023 - Non-pharmacologic & non-opioid therapies preferred § Establish treatment goals with patients § Assess and discuss risks … and benefits – Prescribe naloxone if at high risk § Prescribe immediate-release opioids § Prescribe … the lowest effective dose § Monitor PDMP – ≤50 MME/day preferred – ≥90 MME/day is high risk § Urine … screenings relevant to pain management – all within the past 1 year – Opioid Risk Tool, PHQ 2, PHQ … – Always flag if present: “Factor that may place the patient at risk for an opioid-related harm.”

48. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdf
    September 01, 2022 - assist in reducing their risk. … appointment, the primary care clinician provides educational information to the patient about their personal risks … factors, and identification of resources to address those risks. … Patient has a terminal condition, and the risks of preventive treatment outweigh benefits. … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

49. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdf
    April 01, 2021 - assist in reducing their risk. … appointment, the primary care clinician provides educational information to the patient about their personal risks … factors, and identification of resources to address those risks. … Patient has a terminal condition, and the risks of preventive treatment outweigh benefits. 15 … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

50. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
    January 01, 2020 - assist in reducing their risk. … appointment, the primary care clinician provides educational information to the patient about their risks … factors, and identification of resources to address those risks. … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients … CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk

51. CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making | CDS Connect
    cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-shared
    August 22, 2017 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

52. CDS Connect Work Group Meeting Summary 3-19-2020 (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/1131/CDS%20Connect%20Work%20Group%20March%202020%20Meeting%20Summary.pdf
    March 19, 2020 - Miller showed a video demonstrating the implemented risk calculator being activated and used within … not on all patients with risk factors, but rather chose to trigger on patients with reversible risk … KM elaborated that they found the risk calculator activated by clinicians more for those patients with … borderline risk, rather than high-risk patients. … The ready access to the risk calculation value was enough in supporting clinician’s decision making

53. Dec-2016-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
    January 01, 2016 - ASCVD risk after interventions have been initiated) · PQRS #438 – Statin use for Primary Prevention … · MESA CAC Score, which can double or triple a patient’s risk that was estimated by a calculator. … This score uses a sub-clinical marker, but does not estimate the risk of stroke. … The USPTF guidelines send the clinician to the calculator only if at least 1 risk factor is present. … Assessment Tool (determine if use of this tool occurs immediately if no ASCVD or if at least 1 risk

54. March 2020 CDS Connect Work Group Call (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/1131/CDS%20Connect%20Work%20Group%20March%202020%20Meeting%20Slides.pdf
    March 01, 2020 - American College of Cardiology recommend use of the Atherosclerotic Cardiovascular Disease (ASCVD) risk … estimator: evaluates 10-year and lifetime risk for ASCVD … score and patient values into dynamic risk calculator. o Option for MD to free type and edit value … • Consider different graphic representations of risk besides bar. … Risk Level Indicators • Explore risk bar to provide context and “best case” scenario.

55. AHRQ PCOR CDS Project Kickoff (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository.pdf
    September 21, 2018 - Non-pharmacologic & non-opioid therapies preferred ▪ Establish treatment goals with patients ▪ Assess and discuss risks … and benefits – Prescribe naloxone if at high risk ▪ Prescribe immediate-release opioids ▪ Prescribe … the lowest effective dose ▪ Monitor PDMP – ≤50 MME/day preferred – ≥90 MME/day is high risk ▪ Urine … screenings relevant to pain management – all within the past 1 year – Opioid Risk Tool, PHQ 2, PHQ … – Always flag if present: “Factor that may place the patient at risk for an opioid-related harm.”

56. AHRQ PCOR CDS Project Kickoff (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
    September 21, 2018 - Non-pharmacologic & non-opioid therapies preferred ▪ Establish treatment goals with patients ▪ Assess and discuss risks … and benefits – Prescribe naloxone if at high risk ▪ Prescribe immediate-release opioids ▪ Prescribe … the lowest effective dose ▪ Monitor PDMP – ≤50 MME/day preferred – ≥90 MME/day is high risk ▪ Urine … screenings relevant to pain management – all within the past 1 year – Opioid Risk Tool, PHQ 2, PHQ … – Always flag if present: “Factor that may place the patient at risk for an opioid-related harm.”

57. Warfarin And Ssris Graph V. 5 (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin%20and%20SSRIs%20Graph%20V.%205.pdf
    March 11, 2019 - Warfarin Type of Antidepressant Assess risk … and take action if necessary Increased GI and non-GI bleeding risk is possible Assess risk and … Increased bleeding risk unlikely And SNRIs: clomipramine, desvenlafaxine, duloxetine, … No Yes Use only if benefit outweighs risk Increased GI and non-GI bleeding risk is likely … RED: Class 1: Avoid Combination YELLOW: Class 2/3: Usually Avoid Combination or Minimize Risk GREEN

58. Warfarin And Nsaids V.8 (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin%20and%20NSAIDs%20V.8.pdf
    September 08, 2020 - And Yes No Assess risk and take action if necessary Possible increased risk of bleeding Is patient … Yes Start patient on proton pump inhibitor Assess risk and take action if necessary Possible increased … risk of bleeding No Use NSAIDS only if benefit outweighs risk Increased bleeding risk likely … Topical, Ophthalmic, Non-oral NSAIDs Excluding Risk Factors Affecting Bleeding … Risk - history of upper gastrointestinal bleeding

59. Hook
    cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-10/hook.json
    January 01, 2023 - "conditionExpression": "NoDDimerNoWells", "card": { "summary": "Please assess PE risk … and D-dimer before ordering a CTPA.", "detail": "It is recommended to assess the patient's risk … Use the following link to evaluate the risk.", "indicator": "info", "links": [{ … "label": "Launch PE Risk Assessment Tool", "url": "https://smartcds.alunahealth.com/", … ": "Evaluate D-dimer before Proceeding with CTPA", "detail": "Well's score indicates a low risk

60. Warfarin-Nsaids Mdia Implementation Guide (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
    November 11, 2019 - Implementing and Using This Artifact Description and Purpose of the artifact This artifact aims to address risks … · For Warfarin – NSAIDS rule: · Recommendation: Assess risk and take action if necessary · Rationale … : Possible increased risk of bleeding · Class 1: Red: Avoid Combination · For Warfarin – NSAIDS rule: … · Recommendation: Use only if benefit outweighs risk · Rationale: Increased bleeding risk likely … and take action if necessary Possible increased risk of bleeding 1496 56 Patient is not on PPI